Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK.
Oxidative stress is characterized as an imbalance between the cellular production of oxidants and the cellular antioxidant defenses and contributes to the development of numerous cardiovascular and metabolic disorders, including hypertension and insulin resistance. The effects of prolonged oxidant stress in vitro on the insulin-dependent glucose transport system in mammalian skeletal muscle are not well understood. This study examined the in vitro effects of low-level oxidant stress (60-90 microM, H(2)O(2)) for 4 h on insulin-stimulated (5 mU/ml) glucose transport activity (2-deoxyglucose uptake) and on protein expression of critical insulin signaling factors (insulin receptor (IR), IR substrates IRS-1 and IRS-2, phosphatidylinositol 3-kinase, Akt, and glycogen synthase kinase-3 (GSK-3)) in isolated soleus muscle of lean Zucker rats. This oxidant stress exposure caused significant (50%, p<0.05) decreases in insulin-stimulated glucose transport activity that were associated with selective loss of IRS-1 (59%) and IRS-2 (33%) proteins, increased (64%) relative IRS-1 Ser(307) phosphorylation, and decreased phosphorylation of Akt Ser(473) (50%) and GSK-3beta Ser(9) (43%). Moreover, enhanced (37%) phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK) was observed. Selective inhibition of p38 MAPK (10 microM A304000) prevented a significant portion (29%) of the oxidant stress-induced loss of IRS-1 (but not IRS-2) protein and allowed partial recovery of the impaired insulin-stimulated glucose transport activity. These results indicate that in vitro oxidative stress in mammalian skeletal muscle leads to substantial insulin resistance of distal insulin signaling and glucose transport activity, associated with a selective loss of IRS-1 protein, in part due to a p38 MAPK-dependent mechanism.
Archuleta
Tara L
TL
Muscle Metabolism Laboratory, Department of Physiology, University of Arizona College of Medicine, Tucson, AZ 85721-0093, USA.
Lemieux
Andrew M
AM
Saengsirisuwan
Vitoon
V
Teachey
Mary K
MK
Lindborg
Katherine A
KA
Kim
John S
JS
Henriksen
Erik J
EJ
D000818:Animals; D005260:Female; D005947:Glucose / Q000378:metabolism; D006861:Hydrogen Peroxide / Q000494:pharmacology; D055504:Insulin Receptor Substrate Proteins / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D018384:Oxidative Stress; D051381:Rats; D011924:Rats, Zucker; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
D055504:Insulin Receptor Substrate Proteins; C526296:Irs1 protein, rat; C526299:Irs2 protein, rat; D006861:Hydrogen Peroxide; D048051:p38 Mitogen-Activated Protein Kinases; D005947:Glucose
Free Radic Biol Med. 2006 Jun 15;40(12):2112-25
16785025
Diabetes. 2001 Feb;50(2):404-10
11272154
Arch Physiol Biochem. 2008 Dec;114(5):331-9
19023684
FASEB J. 2004 Jan;18(1):39-51
14718385
Endocr Rev. 2002 Oct;23(5):599-622
12372842
Diabetes. 2003 Jan;52(1):1-8
12502486
Free Radic Biol Med. 2006 Sep 1;41(5):818-24
16895802
Diabetes. 2003 Mar;52(3):634-41
12606502
Am J Physiol Endocrinol Metab. 2005 May;288(5):E996-E1001
15613677
Diabetologia. 2006 Oct;49(10):2463-73
16896943
Curr Drug Targets. 2006 Nov;7(11):1435-41
17100583
J Biol Chem. 2000 Aug 4;275(31):23413-6
10856288
J Biol Chem. 1996 Feb 23;271(8):4138-42
8626753
Free Radic Biol Med. 2006 Jan 1;40(1):3-12
16337874
Diabetologia. 2003 Oct;46(10):1324-8
12937895
J Biol Chem. 1999 Dec 17;274(51):36293-9
10593919
J Biol Chem. 1998 Mar 27;273(13):7228-34
9516415
Metabolism. 2005 Jul;54(7):895-901
15988698
Cell Biochem Biophys. 2007;48(2-3):103-13
17709880
Am J Physiol. 1997 May;272(5 Pt 1):E935-40
9176196
Diabetes. 1998 Oct;47(10):1562-9
9753293
Metabolism. 2004 Sep;53(9):1215-22
15334387
Diabetes. 2008 May;57(5):1216-26
18174527
J Appl Physiol (1985). 1994 May;76(5):1862-7
8063642
Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E615-21
18089761
Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1553-67
16356119
J Biol Chem. 1997 Sep 12;272(37):23086-93
9287309
J Biol Chem. 2002 Dec 27;277(52):50386-95
12393894
J Clin Invest. 2000 Jul;106(2):171-6
10903330
Arch Physiol Biochem. 2007 Oct-Dec;113(4-5):221-7
18158645
Metabolism. 2007 Jul;56(7):931-8
17570255
Diabetologia. 2000 Jul;43(7):821-35
10952453
Diabetologia. 2003 May;46(5):639-48
12750770
Nature. 2006 Apr 13;440(7086):944-8
16612386
Diabetes. 1999 Oct;48(10):1930-6
10512356
Diabetes. 1999 Jul;48(7):1359-64
10389839
Diabetologia. 1999 Aug;42(8):949-57
10491755